ORIC
Oric Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.72
+3.00%0
Insider buys (3m)
8
Insider sells (3m)
-$1.5M
Net value (3m)
+21.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 2, 2026 | Heyman Richard A. · director | Sale | 3,500 | $13 |
| Oct 2, 2026 | Heyman Richard A. · director | Sale | 3,200 | $13 |
| Oct 2, 2026 | Heyman Richard A. · director | M-Exempt | 3,500 | $1.60 |
| Sep 29, 2026 | Piscitelli Dominic · officer: Chief Financial Officer | M-Exempt | 13,400 | $4.36 |
| Sep 29, 2026 | Piscitelli Dominic · officer: Chief Financial Officer | Sale | 13,400 | $14 |
| Sep 25, 2026 | Piscitelli Dominic · officer: Chief Financial Officer | Sale | 100 | $14 |
| Sep 25, 2026 | Piscitelli Dominic · officer: Chief Financial Officer | M-Exempt | 600 | $4.36 |
| Sep 25, 2026 | Piscitelli Dominic · officer: Chief Financial Officer | Sale | 500 | $14 |
| Aug 28, 2026 | Piscitelli Dominic · officer: Chief Financial Officer | Sale | 77,000 | $14 |
| Aug 28, 2026 | Piscitelli Dominic · officer: Chief Financial Officer | M-Exempt | 52,000 | $4.36 |
| Aug 28, 2026 | Piscitelli Dominic · officer: Chief Financial Officer | M-Exempt | 25,000 | $6.00 |
| Jul 28, 2026 | Heyman Richard A. · director | Sale | 7,000 | $12 |
| Jul 28, 2026 | Heyman Richard A. · director | M-Exempt | 3,500 | $1.60 |
| Jul 28, 2026 | Heyman Richard A. · director | Sale | 6,100 | $12 |
| Jul 8, 2026 | Heyman Richard A. · director | Sale | 300 | $12 |
| Feb 26, 2026 | Piscitelli Dominic · officer: Chief Financial Officer | M-Exempt | 52,000 | $4.36 |
| Feb 26, 2026 | Piscitelli Dominic · officer: Chief Financial Officer | Sale | 52,000 | $14 |
| Jan 20, 2026 | Heyman Richard A. · director | Sale | 3,200 | $12 |
| Jan 20, 2026 | Heyman Richard A. · director | Sale | 3,500 | $12 |
| Jan 6, 2026 | Chacko Jacob · director, officer: PRESIDENT AND CEO | A-Award | 112,500 | $0.00 |
| Jan 6, 2026 | Chacko Jacob · director, officer: PRESIDENT AND CEO | A-Award | 675,000 | $8.17 |
| Jan 6, 2026 | Multani Pratik S · officer: Chief Medical Officer | A-Award | 35,500 | $0.00 |
| Jan 6, 2026 | Heyman Richard A. · director | A-Award | 40,000 | $8.17 |
| Jan 6, 2026 | Multani Pratik S · officer: Chief Medical Officer | A-Award | 214,000 | $8.17 |
| Jan 6, 2026 | Piscitelli Dominic · officer: Chief Financial Officer | A-Award | 34,500 | $0.00 |
| Jan 6, 2026 | Hoerter Steven L. · director | A-Award | 40,000 | $8.17 |
| Jan 6, 2026 | Kunkel Lori Anne · director | A-Award | 40,000 | $8.17 |
| Jan 6, 2026 | You Angie · director | A-Award | 40,000 | $8.17 |
| Jan 6, 2026 | Piscitelli Dominic · officer: Chief Financial Officer | A-Award | 206,500 | $8.17 |
| Jan 6, 2026 | Dier Mardi · director | A-Award | 40,000 | $8.17 |
Institutional positioning
13F filings over the trailing two quarters
New 70Increased 139Reduced 106Sold out 31
| Filer | Action | Shares | Filed |
|---|---|---|---|
| NEXTECH INVEST, LTD. | Unchanged | 7,162,637 | May 15, 2026 |
| Nextech Invest, Ltd. | Unchanged | 7,162,637 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 6,823,973 | Aug 7, 2026 |
| ECOR1 CAPITAL, LLC | Unchanged | 6,728,116 | May 15, 2026 |
| EcoR1 Capital, LLC | Unchanged | 6,728,116 | Aug 14, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 6,617,554 | Aug 14, 2026 |
| BLACKROCK, INC. | Increased | 5,984,552 | May 13, 2026 |
| VIKING GLOBAL INVESTORS LP | Reduced | 5,824,533 | May 15, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 5,387,783 | May 15, 2026 |
| VIKING GLOBAL INVESTORS LP | Reduced | 5,126,762 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 4,894,000 | Sep 22, 2026 |
| PFIZER INC | Reduced | 4,780,401 | May 12, 2026 |
| SR ONE CAPITAL MANAGEMENT, LP | Increased | 4,615,384 | Aug 12, 2026 |
| SR ONE CAPITAL MANAGEMENT, LP | Unchanged | 4,514,929 | May 14, 2026 |
| ALKEON CAPITAL MANAGEMENT LLC | Unchanged | 4,504,096 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 2, 2026